Implementation and Validation of Telepathology Triage at Cancer Referral Center in Rural Rwanda

• Published in: Journal of global oncology Vol. 2; no. 2; pp. 76 - 82
• Main Authors: Mpunga, Tharcisse, Hedt-Gauthier, Bethany L, Tapela, Neo, Nshimiyimana, Irenee, Muvugabigwi, Gaspard, Pritchett, Natalie, Greenberg, Lauren, Benewe, Origene, Shulman, David S, Pepoon, James R, Shulman, Lawrence N, Milner, Jr, Danny A
• Format: Journal Article
• Language: English
• Published: United States American Society of Clinical Oncology 01.04.2016
• Subjects: Cost Effectiveness; Original Reports; Quality of Care
• ISSN: 2378-9506; 2378-9506
• DOI: 10.1200/JGO.2015.002162

Connecting a cancer patient to the appropriate treatment requires the correct diagnosis provided in a timely manner. In resource-limited settings, the anatomic pathology bridge to efficient, accurate, and timely cancer care is often challenging. In this study, we present the first phase of an anatomic telepathology triage system, which was implemented and validated at the Butaro District Hospital in northern rural Rwanda. Select cases over a 9-month period in three segments were evaluated by static image telepathology and were independently evaluated by standard glass slide histology. Each case via telepathology was classified as malignant, benign, infectious/inflammatory, or nondiagnostic and was given an exact histologic diagnosis. For cases triaged as appropriate for telepathology, correlation with classification and exact diagnosis demonstrated greater than 95% agreement over the study. Cases in which there was disagreement were analyzed for cause, and the triage process was adjusted to avoid future problems. Challenges to obtaining a correct and complete diagnosis with telepathology alone included the need for immunohistochemistry, assessment of the quality of images, and the lack of images representing an entire sample. The next phase of the system will assess the effect of telepathology triage on turnaround time and the value of on-site immunohistochemistry in reducing that metric and the need for evaluation outside of telepathology.